Patents Assigned to Greenyn Biotechnology Co., Ltd.
-
Patent number: 12180306Abstract: The invention provides an anti-allergic peptide and a use thereof for immune regulation and anti-allergy, the anti-allergic peptide is capable of inhibiting secretion of cytokines related to allergic reactions and regulating allergic reactions, and the anti-allergic peptide comprises an amino acid sequence shown in SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 4 or SEQ ID No: 5, or a homologous amino acid sequence derived from substitution, deletion, and addition of one amino acid or more than one amino acid of any of the above sequences.Type: GrantFiled: December 2, 2022Date of Patent: December 31, 2024Assignee: GREENYN BIOTECHNOLOGY CO., LTDInventors: Pang Kuei Hsu, Yu Cheng Lin, Chih Kuo Kao, Chia Feng Wu
-
Patent number: 12138287Abstract: A usage of a Antrodia cinnamomea powder for preparation of a composition for dispelling the effects of alcohol, which means that by administering an effective amount of the Antrodia cinnamomea powder disclosed in the invention to an subject, is capable of accelerating metabolism of alcohol and/or acetaldehyde in the subject's body, reducing a content of alcohol and/or acetaldehyde in blood, and shortening the time of the subject generating intoxicated reaction in order to achieve an efficacy of dispelling the effects of alcohol.Type: GrantFiled: July 24, 2023Date of Patent: November 12, 2024Assignee: GREENYN BIOTECHNOLOGY CO., LTDInventors: Pang-Kuei Hsu, Chia-Feng Wu
-
Patent number: 11759488Abstract: The invention provides a usage of a Antrodia cinnamomea powder for preparation of a composition for dispelling the effects of alcohol, which means that by administering an effective amount of the Antrodia cinnamomea powder disclosed in the invention to an subject, is capable of accelerating metabolism of alcohol and/or acetaldehyde in the subject's body, reducing a content of alcohol and/or acetaldehyde in blood, and shortening the time of the subject generating intoxicated reaction in order to achieve an efficacy of dispelling the effects of alcohol.Type: GrantFiled: March 16, 2021Date of Patent: September 19, 2023Assignee: GREENYN BIOTECHNOLOGY CO., LTDInventors: Pang-Kuei Hsu, Chia-Feng Wu
-
Patent number: 11602520Abstract: The invention discloses a c-Met regulatory composition and its method for treating liver disease, a main component of the c-Met regulatory composition comprises Antrodin A and/or DMB (4,7-Dimethoxy-5-methyl-1,3-benzodioxole) capable of effectively regulating gene expression related to cell regeneration and cytothesis in hepatic cells, such as c-Met, Notch, etc., to achieve efficacies of repairing damaged hepatic cells and promoting hepatocyte regeneration.Type: GrantFiled: October 14, 2021Date of Patent: March 14, 2023Assignee: GREENYN BIOTECHNOLOGY CO., LTDInventors: Pang-Kuei Hsu, Chun-Yi Ho, Chia-Feng Wu
-
Patent number: 11149239Abstract: This invention disclosed a method for preparing low-sugar vegetable and fruit enzyme product comprising obtaining a fruit or/and vegetable as a material; fermenting the material for at least three times sequentially, and producing an enzyme product, wherein the first fermentation is yeast fermentation, the second fermentation is acetic acid bacteria fermentation and the third fermentation is lactic acid bacteria fermentation; and the sugar content of the enzyme product is less than 5 wt %, especially, in a predetermined fermentation condition, the sugar content of the enzyme product is less than 2.5 wt %.Type: GrantFiled: May 1, 2019Date of Patent: October 19, 2021Assignee: Greenyn Biotechnology Co., LtdInventors: Pang-Kuei Hsu, Yu-Cheng Lin, Chia-Feng Wu
-
Patent number: 10356988Abstract: This present invention disclosed a method for culturing Ophiocordyceps sinensis by inoculating a fungus inoculum onto a medium, culturing with a culturing condition in the dark room, and then culturing under the light for at least four weeks. According to the method for culturing O. sinensis disclosed in this present invention, the cultured O. sinensis has better growth rate and its composition and content of active ingredients are similar with wild O. sinensis.Type: GrantFiled: April 19, 2016Date of Patent: July 23, 2019Assignees: Tunghai University, Greenyn Biotechnology Co., LtdInventors: Fan-Chiang Yang, Yi-Chuan Shih
-
Patent number: 10285972Abstract: The present invention discloses a method for producing trans-2-nonadecyl-4-hydroxymethyl-1,3-dioxolane comprising mixing alkanes and pyridinium chlorochromat for an oxidation reaction; obtaining a product by the oxidation reaction for processing an aldolization reaction and then purifying for obtaining a trans-2-nonadecyl-4-hydroxymethyl-1,3-dioxolane compound. According to the method of the present invention, it is able to promote the productivity and reduce the cost.Type: GrantFiled: August 4, 2016Date of Patent: May 14, 2019Assignees: GREENYN BIOTECHNOLOGY CO., LTDInventors: Min-Hsiung Pan, Chi-I Chang, Chia-Feng Wu, Pang-Kuei Hsu
-
Patent number: 9458421Abstract: The invention discloses a culture method for Antrodia cinnamomea to elevate the amounts and types of the bioactive components in Antrodia cinnamomea through controlling the wavelength and intensity of the light. Furthermore, the modification of the environmental factors such as water content, composition and relative amount of the culture medium, and the culture temperature are capable of increasing the amounts and types of the bioactive components in Antrodia cinnamomea.Type: GrantFiled: January 6, 2014Date of Patent: October 4, 2016Assignees: TUNGHAI UNIVERSITY, GREENYN BIOTECHNOLOGY CO., LTD.Inventors: Fan-Chiang Yang, Chia-Li Wu, Ya-Chen Chi
-
Publication number: 20150052639Abstract: The invention discloses a culture method for Antrodia cinnamomea to elevate the amounts and types of the bioactive components in Antrodia cinnamomea through controlling the wavelength and intensity of the light. Furthermore, the modification of the environmental factors such as water content, composition and relative amount of the culture medium, and the culture temperature are capable of increasing the amounts and types of the bioactive components in Antrodia cinnamomea.Type: ApplicationFiled: January 6, 2014Publication date: February 19, 2015Applicants: Greenyn Biotechnology Co., Ltd., Tunghai UniversityInventors: Fan-Chiang YANG, Chia-Li WU, Ya-Chen CHI
-
Publication number: 20150051272Abstract: The invention discloses the uses of hydroxyl polymethoxylflavones and derivative thereof that are relative to inhibit adipogenesis and lower lipid accumulation, wherein the hydroxyl polymethoxylflavones is obtained from the peels of Citrus genus plants. Therefore, the hydroxyl polymethoxylflavones that of a therapeutically effective amount not only can be a medical compound for treatment obesity or fatty liver, but also can be a food element.Type: ApplicationFiled: January 28, 2014Publication date: February 19, 2015Applicants: Greenyn Biotechnology Co., LtdInventors: Min-Hsiung PAN, Chia-Li WU
-
Patent number: 8946288Abstract: The invention discloses the uses of hydroxyl polymethoxylflavones and derivative thereof that are relative to inhibit adipogenesis and lower lipid accumulation, wherein the hydroxyl polymethoxylflavones is obtained from the peels of Citrus genus plants. Therefore, the hydroxyl polymethoxylflavones that of a therapeutically effective amount not only can be a medical compound for treatment obesity or fatty liver, but also can be a food element.Type: GrantFiled: January 28, 2014Date of Patent: February 3, 2015Assignees: Greenyn Biotechnology Co., Ltd.Inventors: Min-Hsiung Pan, Chia-Li Wu